Boston Scientific Corporation (BVMF:B1SX34)

Market Cap	590.38B -33.4%
Revenue (ttm)	110.57B +19.9%
Net Income	15.96B +56.3%
EPS	10.69 +55.2%
Shares Out	n/a
PE Ratio	36.99
Forward PE	21.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	69
Open	412.75
Previous Close	412.75
Day's Range	396.96 - 412.75
52-Week Range	396.96 - 615.11
Beta	0.66
RSI	22.64
Earnings Date	Feb 4, 2026

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 53,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: B1SX34

Financial Performance

In 2025, Boston Scientific's revenue was $20.07 billion, an increase of 19.87% compared to the previous year's $16.75 billion. Earnings were $2.90 billion, an increase of 56.40%.

Financial numbers in USD